🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate immunogenicity and safety of menin...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-07-01
Trial ID
NCT01144663
Treatments Being Tested
The purpose of the study is to characterize the immunogenicity \& safety of...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-02-13
Trial ID
NCT00614614
This study evaluates the immunogenicity and safety of the meningococcal con...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-01-27
Trial ID
NCT01340898
Treatments Being Tested
This study has 2 phases, a vaccination phase and a long-term follow-up phas...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-02-07
Trial ID
NCT00427908
Treatments Being Tested
Meningococcal disease is mostly caused by N. meningitidis of serogroups A, ...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-12-23
Trial ID
NCT00356369
Treatments Being Tested
The purpose of this study is to evaluate safety and immunogenicity of GSK B...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-01-11
Trial ID
NCT01755689
Treatments Being Tested
This study will demonstrate the non-inferiority of GSK Biologicals' meningo...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-04-11
Trial ID
NCT00465816
Treatments Being Tested